CDH1 and ovarian carcinoma: The National Comprehensive Cancer Network (NCCN) guidelines recommend germline testing of high‐penetrance breast and/or ovarian cancer susceptibility genes, which they identify as BRCA1, BRCA2, CDH1, PALB2, PTEN, and TP53 for all women with epithelial ovarian cancer, regardless of pathology.17